ClostraBio, Inc.

ClostraBio, Inc.

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://clostrabio.com

Last Round

VC Round

Mar 20, 2025

Total Funding Raised

$7.76M

Company Overview

ClostraBio, Inc. is a biotechnology company that develops therapeutics, next-generation probiotics, and dietary supplements to treat gut health, inflammatory bowel disease (IBD), and food allergies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

microbiome therapeuticsbutyrate deliverygut barrier functionfood allergy treatmentleaky gutinflammatory bowel diseaseIBD treatmentulcerative colitisdrug delivery platformprobiotic ingredientlive biotherapeutic productsnext-gen probioticgut healthB2B ingredient supplierAnaerostipes caccaemicelle deliveryblock copolymers

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ClostraBio, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ClostraBio, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 20, 2025
Series ASep 30, 2022
SeedJan 9, 2018
GrantJun 5, 2017
GrantJun 1, 2017

Key People

Founding team and executive leadership

Ritu Shah

Chief Executive Officer

Executive Team

ClostraBio, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Partnered with Maypro Group to expand commercial reach.

  • Jan 8, 2026

    Fully enrolled placebo-controlled study for CLB101(TM).

ClostraBio, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ClostraBio, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ClostraBio, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range13
Year Founded2016
Last FundingMar 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.